Decibel Therapeutics Stock Short Ratio
Decibel Therapeutics fundamentals help investors to digest information that contributes to Decibel Therapeutics' financial success or failures. It also enables traders to predict the movement of Decibel Stock. The fundamental analysis module provides a way to measure Decibel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Decibel Therapeutics stock.
Decibel |
Decibel Therapeutics Company Short Ratio Analysis
Decibel Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Decibel Therapeutics Short Ratio | 0.60 X |
Most of Decibel Therapeutics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Decibel Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Decibel Therapeutics has a Short Ratio of 0.6 times. This is 84.62% lower than that of the Biotechnology sector and 91.9% lower than that of the Health Care industry. The short ratio for all United States stocks is 85.0% higher than that of the company.
Decibel Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Decibel Therapeutics' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Decibel Therapeutics could also be used in its relative valuation, which is a method of valuing Decibel Therapeutics by comparing valuation metrics of similar companies.Decibel Therapeutics is currently under evaluation in short ratio category among its peers.
Decibel Fundamentals
| Return On Equity | -0.77 | |||
| Return On Asset | -0.33 | |||
| Current Valuation | 62.95 M | |||
| Shares Outstanding | 25.13 M | |||
| Shares Owned By Insiders | 13.35 % | |||
| Shares Owned By Institutions | 61.90 % | |||
| Number Of Shares Shorted | 78.33 K | |||
| Price To Book | 0.67 X | |||
| EBITDA | (62.49 M) | |||
| Net Income | (63.01 M) | |||
| Cash And Equivalents | 125.65 M | |||
| Cash Per Share | 5.03 X | |||
| Total Debt | 14.05 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 6.18 X | |||
| Book Value Per Share | 2.12 X | |||
| Cash Flow From Operations | (56.9 M) | |||
| Short Ratio | 0.60 X | |||
| Earnings Per Share | (2.56) X | |||
| Target Price | 7.63 | |||
| Number Of Employees | 68 | |||
| Beta | -0.21 | |||
| Market Capitalization | 127.14 M | |||
| Total Asset | 123.37 M | |||
| Retained Earnings | (277.52 M) | |||
| Working Capital | 85.59 M | |||
| Z Score | 1.44 | |||
| Net Asset | 123.37 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |